Detalhe da pesquisa
1.
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study.
Brain
; 145(8): 2796-2805, 2022 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325059
2.
Pregnancy in multiple sclerosis women with relapses in the year before conception increases the risk of long-term disability worsening.
Mult Scler
; 28(3): 472-479, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34132146
3.
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register.
Mult Scler
; 28(14): 2243-2252, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35971322
4.
Cost-utility analysis of teriflunomide in naïve vs. previously treated patients with relapsing-remitting multiple sclerosis in Italy.
Neurol Sci
; 43(8): 4933-4944, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35420360
5.
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study.
Eur J Neurol
; 28(4): 1299-1307, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33305459
6.
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis.
Brain
; 143(10): 3013-3024, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32935843
7.
Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study results.
Neurol Sci
; 42(7): 2837-2845, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33205373
8.
Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.
Neurol Sci
; 37(7): 1113-7, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27083895
9.
Multiple sclerosis--new treatment modalities.
Indian J Med Res
; 142(6): 647-54, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26831413
10.
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.
J Neurol Neurosurg Psychiatry
; 85(8): 845-50, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24403285
11.
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.
BMC Neurol
; 14: 114, 2014 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24884599
12.
Intravenous or subcutaneous natalizumab in patients with relapsing-remitting multiple sclerosis: investigation on efficiency and savings-the EASIER study.
J Neurol
; 271(1): 340-354, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715789
13.
Multiple Sclerosis Progression and Relapse Activity in Children.
JAMA Neurol
; 81(1): 50-58, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38010712
14.
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.
J Neurol
; 2024 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38805052
15.
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study.
Neurotherapeutics
; : e00363, 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38714462
16.
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry.
J Neurol
; 271(3): 1150-1159, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38135850
17.
Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH study.
Mult Scler Relat Disord
; 70: 104474, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36584654
18.
Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study.
J Neurol
; 270(10): 4687-4696, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37405689
19.
A gender-related action of IFNbeta-therapy was found in multiple sclerosis.
J Transl Med
; 10: 223, 2012 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23148845
20.
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study.
BMC Neurol
; 12: 165, 2012 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-23276328